Investing.com — WW International (NASDAQ:WW) Inc. has initiated discussions to address the company’s balance sheet issues, according to Bloomberg, citing sources familiar with the situation. The company, known for its WeightWatchers brand and diet-related products and services, is facing increased competition from new weight-loss drugs.
These talks are still in the early stages, the sources noted. WW International had previously announced during its third-quarter earnings call that it had hired advisers to assist in evaluating options for its capital structure.
The company is collaborating with PJT Partners (NYSE:PJT) in this process, according to the same sources. Additionally, a group of the company’s creditors has engaged Houlihan Lokey Inc (NYSE:HLI). and Gibson Dunn & Crutcher as advisers in preparation for discussions with WW International.
The company’s term loan, due in 2028, is currently quoted at around 23 cents on the dollar. This is a significant drop from 71.75 cents at the end of 2023, as per data compiled by Bloomberg.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
